Nova Tina Susan — SEC insider filings
SEC reporting owner CIK 1302605. 17 insider filings on record with FilingPulse; latest filed 2026-11-02.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2020-08-28 to 2026-11-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 17,300 shares, $1,175,303 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 31.
- Largest priced transaction: sale of 17,300 shares @ $67.94 ($1,175,303) in ARENA PHARMACEUTICALS INC, filed 2020-08-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARENA PHARMACEUTICALS INC (ARNA) | Director | 3 | — | 1 leg · 17,300 sh · $1,175,303 | 16 |
| EXAGEN INC. (XGN) | Director | 6 | — | — | 6 |
| Azenta, Inc. (AZTA) | Director | 4 | — | — | 4 |
| VERACYTE, INC. (VCYT) | President, CLIA U.S. | 2 | — | — | 3 |
| Aurinia Pharmaceuticals Inc. (AUPH) | Director | 2 | — | — | 2 |
Insider filings — Nova Tina Susan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-02 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 56,200 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 23,931 (derivative) @ $0 | EDGAR |
| 2026-02-06 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 5,663 @ $27.85 | EDGAR |
| 2025-06-12 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 63,724 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 4,040 @ $52.32 | EDGAR |
| 2024-06-12 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 2,465 @ $65.93 | EDGAR |
| 2023-06-20 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2023-02-15 | 4 | Azenta, Inc. (AZTA) | Grant/award (A): 3,604 @ $0 | EDGAR |
| 2022-06-21 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2022-03-11 | 4 | ARENA PHARMACEUTICALS INC (ARNA) | Other (J): 17,776 · Other (J): 3,067 · Disposition to issuer (D): 4,800 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +2 more | EDGAR |
| 2022-03-07 | 4 | VERACYTE, INC. (VCYT) | Grant/award (A): 56,546 @ $0 · Grant/award (A): 103,043 (derivative) @ $0 | EDGAR |
| 2022-03-04 | 4 | VERACYTE, INC. (VCYT) | Tax withholding (F): 10,695 @ $27.84 | EDGAR |
| 2021-06-21 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | ARENA PHARMACEUTICALS INC (ARNA) | Grant/award (A): 3,067 @ $0 · Grant/award (A): 7,202 (derivative) @ $0 | EDGAR |
| 2020-08-28 | 4 | ARENA PHARMACEUTICALS INC (ARNA) | Option exercise (M): 1,200 @ $14.90 · Option exercise (M): 3,600 @ $12.70 · Option exercise (M): 12,500 @ $20 · Sale (S): 17,300 @ $67.94 · Option exercise (M): 1,200 (derivative) @ $0 · Option exercise (M): 3,600 (derivative) @ $0 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1302605 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs